Summary
- Current Price
- As of today, RXRX price is $3.49, down -2.51% on
- Current Price All-Time High
- RXRX price is currently -91.85% below its historical high of $42.81 set on
- Market Cap
- RXRX current market cap is $2B, down -46.76% year-over-year
- PE Ratio
- RXRX PE ratio is unknown
- Revenue
- RXRX current annual revenue is $58.84M, up +32.00% year-over-year
- Next Earnings
- The next earnings release for RXRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Recursion Pharmaceuticals, Inc. |
| Ticker | NASDAQ: RXRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | recursion.com |
| Employees | 800 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.49 | |
| Price, 1D Change | -2.51% | |
| $2B | ||
| - | ||
| - | ||
| 2.44 | ||
| $59M | ||
| Revenue, 1Y Change | +32.00% | |
| -$1.69 | ||
| EPS, 1Y Change | -7.13% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.69 | ||
| EPS Estimate | -$1.60 | |
| EPS Est. Change | +5.29% | |
| $58.84M | ||
| Revenue Estimate | $61.61M | |
| Revenue Est. Change | +4.71% | |
| Current Price | $3.49 | |
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +100.57% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.64 | -$1.58 | +3.76% | |
| -$1.54 | -$1.69 | -9.71% | |
| -$1.60 | N/A | +5.29% | |
| -$1.17 | N/A | +30.87% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $52.14M | $44.58M | -14.51% | |
| $67.80M | $58.84M | -13.22% | |
| $61.61M | N/A | +4.71% | |
| $82.66M | N/A | +40.48% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.49 | |
| $4.92 | ||
| SMA 200 vs Price | +40.93% | |
| $4.39 | ||
| SMA 50 vs Price | +25.66% | |
| 2.44 | ||
| $0.28 | ||
| 33.44 | ||
| 84.80% | ||
| 87.27% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $58.84M | ||
| -$1.69 | ||
| $13.25M | ||
| -7.81% | ||
| -$479.00M | ||
| -818.98% | ||
| -$463.66M | ||
| -792.75% | ||
| -$426.72M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 3.81 | ||
| 3.81 | ||
| -294.67 | ||
| 3 | ||
| 0.68 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 41.64 | ||
| 1.74 | ||
| -1.92 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.03B | ||
| $594.35M | ||
| $1.45B | ||
| $714.27M | ||
| $413.82M | ||
| $187.47M | ||
| $108.49M | ||
| $22.22M | ||
| $21.61M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $537.49M | ||
| $492.25M | ||
| $63.43M | ||
| $178.18M | ||
| $36.49M | ||
| $1.57M | ||
| -$1.13M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$359.17M | ||
| $260.06M | ||
| $304.12M | ||
| $17.05M | ||
| -$376.22M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Needham | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Needham | → | |
| Leerink Partners | → | |
| Needham | → | |
| Keybanc | → |
Analyst sentiment
Institutional ownership
Screeners with RXRX
FAQ
What is the ticker symbol for Recursion Pharmaceuticals, Inc.?
The ticker symbol for Recursion Pharmaceuticals, Inc. is NASDAQ:RXRX
Does Recursion Pharmaceuticals, Inc. pay dividends?
No, Recursion Pharmaceuticals, Inc. does not pay dividends
What sector is Recursion Pharmaceuticals, Inc. in?
Recursion Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Recursion Pharmaceuticals, Inc. in?
Recursion Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Recursion Pharmaceuticals, Inc. based in?
Recursion Pharmaceuticals, Inc. is headquartered in United States
When did Recursion Pharmaceuticals, Inc. go public?
Recursion Pharmaceuticals, Inc. initial public offering (IPO) was on April 16, 2021
Is Recursion Pharmaceuticals, Inc. in the S&P 500?
No, Recursion Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Recursion Pharmaceuticals, Inc. in the NASDAQ 100?
No, Recursion Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Recursion Pharmaceuticals, Inc. in the Dow Jones?
No, Recursion Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Recursion Pharmaceuticals, Inc. last earnings report?
Recursion Pharmaceuticals, Inc.'s most recent earnings report was on November 5, 2025
When does Recursion Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Recursion Pharmaceuticals, Inc. is February 26, 2026
Data Sources & References
- RXRX Official Website www.recursion.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1601830/000160183025000166/0001601830-25-000166-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1601830/000160183025000035/0001601830-25-000035-index.htm
- RXRX Profile on Yahoo Finance finance.yahoo.com/quote/RXRX
- RXRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rxrx